81 related articles for article (PubMed ID: 2465004)
1. Expression of an enzymatically active murine retroviral reverse transcriptase in human cells.
Jean-Jean O; Moyret C; Bernard D; de Recondo AM; Rossignol JM
Biochem Biophys Res Commun; 1989 Jan; 158(2):595-602. PubMed ID: 2465004
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
Hizi A; Tal R; Hughes SH
Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
[TBL] [Abstract][Full Text] [Related]
3. Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.
Blain SW; Goff SP
J Biol Chem; 1993 Nov; 268(31):23585-92. PubMed ID: 7693692
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase.
Hostomsky Z; Hostomska Z; Hudson GO; Moomaw EW; Nodes BR
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1148-52. PubMed ID: 1705027
[TBL] [Abstract][Full Text] [Related]
5. Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.
Kotewicz ML; Sampson CM; D'Alessio JM; Gerard GF
Nucleic Acids Res; 1988 Jan; 16(1):265-77. PubMed ID: 2448747
[TBL] [Abstract][Full Text] [Related]
6. Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.
Levin JG; Crouch RJ; Post K; Hu SC; McKelvin D; Zweig M; Court DL; Gerwin BI
J Virol; 1988 Nov; 62(11):4376-80. PubMed ID: 2459414
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase.
Repaske R; Hartley JW; Kavlick MF; O'Neill RR; Austin JB
J Virol; 1989 Mar; 63(3):1460-4. PubMed ID: 2464706
[TBL] [Abstract][Full Text] [Related]
8. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
Kögel D; Aboud M; Flügel RM
Virology; 1995 Oct; 213(1):97-108. PubMed ID: 7483284
[TBL] [Abstract][Full Text] [Related]
9. Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.
Tanese N; Telesnitsky A; Goff SP
J Virol; 1991 Aug; 65(8):4387-97. PubMed ID: 1712862
[TBL] [Abstract][Full Text] [Related]
10. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
Tisdale M; Schulze T; Larder BA; Moelling K
J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
[TBL] [Abstract][Full Text] [Related]
11. Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products.
Hu YW; Kang CY
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4596-600. PubMed ID: 1711203
[TBL] [Abstract][Full Text] [Related]
12. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
Telesnitsky A; Goff SP
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1276-80. PubMed ID: 7679498
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.
Hizi A; Hughes SH; Shaharabany M
Virology; 1990 Apr; 175(2):575-80. PubMed ID: 1691564
[TBL] [Abstract][Full Text] [Related]
14. Expression of enzymatically active reverse transcriptase in Escherichia coli.
Tanese N; Roth M; Goff SP
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4944-8. PubMed ID: 2410910
[TBL] [Abstract][Full Text] [Related]
15. Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.
Tanese N; Goff SP
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1777-81. PubMed ID: 2450347
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
17. Substrate binding domain of murine leukemia virus reverse transcriptase. Identification of lysine 103 and lysine 421 as binding site residues.
Basu A; Nanduri VB; Gerard GF; Modak MJ
J Biol Chem; 1988 Feb; 263(4):1648-53. PubMed ID: 2448299
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
[TBL] [Abstract][Full Text] [Related]
19. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
Wilhelm M; Boutabout M; Wilhelm FX
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427
[TBL] [Abstract][Full Text] [Related]
20. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
